Diagnostic Imaging Market Scope And Analysis

Report Code : TIPHE100001107
Category : Life Sciences

No. of Pages : 150

Buy Now

Diagnostic Imaging Market Scope, Growth, Size and Share by 2031

Buy Now

Diagnostic Imaging Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 39.93 Billion
Market Size by 2031	US$ 60.17 Billion
Global CAGR (2023 - 2031)	5.26%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Modality X-Ray CT Endoscopy Ultrasound MRI Nuclear Imaging Mammography By Application Cardiology Oncology Neurology Orthopedics Gastroenterology Obstetrics and Gynecology By End User Hospital and Clinics Diagnostic Imaging Centers Ambulatory Surgical Centers
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	General Electric Company Siemens Healthineers Koninklijke Philips N V KARL STORZ SE Co KG FUJIFILM Holdings Corporation Canon Inc Hologic Inc Carestream Health Inc Stryker Corporation Olympus Corporation

Diagnostic Imaging Market News and Recent Developments

The Diagnostic Imaging market is evaluated by gathering qualitative and quantitative data from primary and secondary research, which includes essential corporate publications, association data, and databases. A few of the developments in the Diagnostic Imaging market are listed below:

Wipro GE Healthcare announced the launch of its next-generation Revolution Aspire CT (Computed Tomography) scanner. Revolution Aspire is an advanced imaging solution designed and manufactured end-to-end in India, at the newly launched Wipro GE Medical Devices Manufacturing plant, in line with ‘Atmanirbhar Bharat’ initiative. The CT system is equipped with higher imaging intelligence to improve clinical confidence when diagnosing diseases and anomalies. (Source: GE HealthCare, Press Release, 2022)
Zionexa, a leading innovator of in-vivo oncology and neurology biomarkers that help enable more personalized healthcare, has been acquired by GE Healthcare. Cerianna (fluoroestradiol F-18), an FDA-approved PET imaging agent used as an adjunct to biopsy for the detection of oestrogen receptor (ER) positive lesions to help inform treatment selection for patients with recurrent or metastatic breast cancer, is being scaled up by the company. (Source: GE HealthCare, Press Release, 2021)

Diagnostic Imaging Market Report Coverage and Deliverables

The “Diagnostic Imaging Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering below areas:

Diagnostic Imaging market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Diagnostic Imaging market trends, as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST/Porter’s Five Forces and SWOT analysis
Diagnostic Imaging market analysis covering key market trends, global and regional framework, significant players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments in the Diagnostic Imaging market
Detailed company profiles